The emerging role of nutrition in Parkinson's disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abbott, 2003, Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study, J. Neurol, 250, III30, 10.1007/s00415-003-1306-7
Aguiar, 2006, Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats, Pharmacol. Biochem. Behav, 84, 415, 10.1016/j.pbb.2006.05.027
Akbar, 2002, Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway, J. Neurochem, 82, 655, 10.1046/j.1471-4159.2002.01015.x
Alcalay, 2012, The association between Mediterranean diet adherence and Parkinson's disease, Mov. Disord, 27, 771, 10.1002/mds.24918
Altman, 2011, Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study, Mov. Disord, 26, 2427, 10.1002/mds.23873
Alvira, 2007, Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons, Neuroscience, 147, 746, 10.1016/j.neuroscience.2007.04.029
Ambani, 1975, Brain peroxidase and catalase in Parkinson disease, Arch. Neurol, 32, 114, 10.1001/archneur.1975.00490440064010
Anandhan, 2012, Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease, Brain Res, 1433, 104, 10.1016/j.brainres.2011.11.021
Anderson, 1999, Dietary factors in Parkinson's disease: the role of food groups and specific foods, Mov. Disord, 14, 21, 10.1002/1531-8257(199901)14:121::AID-MDS10063.0.CO;2-Y
Andreadou, 2009, Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration, Clin. Neurol. Neurosurg, 111, 724, 10.1016/j.clineuro.2009.06.012
Aneja, 2004, Theaflavin, a black tea extract, is a novel anti-inflammatory compound, Crit. Care Med, 32, 2097, 10.1097/01.CCM.0000142661.73633.15
Ascherio, 2003, Caffeine, postmenopausal estrogen, and risk of Parkinson's disease, Neurology, 60, 790, 10.1212/01.WNL.0000046523.05125.87
Ascherio, 2001, Prospective study of caffeine consumption and risk of Parkinson's disease in men and women, Ann. Neurol, 50, 56, 10.1002/ana.1052
Babenko, 2012, Epigenetic programming of neurodegenerative diseases by an adverse environment, Brain Res, 1444, 96, 10.1016/j.brainres.2012.01.038
Baluchnejadmojarad, 2009, Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model, Phytother. Res, 23, 132, 10.1002/ptr.2564
Barichella, 2009, Major nutritional issues in the management of Parkinson's disease, Mov. Disord, 24, 1881, 10.1002/mds.22705
Barkhoudarian, 2011, Preclinical jockeying on the translational track of adenosine A2A receptors, Exp. Neurol, 228, 160, 10.1016/j.expneurol.2010.12.022
Bastianetto, 2006, Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity, Eur. J. Neurosci, 23, 55, 10.1111/j.1460-9568.2005.04532.x
Bazan, 2009, Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease, J. Lipid Res, 50, S400, 10.1194/jlr.R800068-JLR200
Beal, 2003, Mitochondria, oxidative damage, and inflammation in Parkinson's disease, Ann. N. Y. Acad. Sci, 991, 120, 10.1111/j.1749-6632.2003.tb07470.x
Benedetti, 2000, Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study, Neurology, 55, 1350, 10.1212/WNL.55.9.1350
Berry, 1991, A balanced carbohydrate: protein diet in the management of Parkinson's disease, Neurology, 41, 1295, 10.1212/WNL.41.8.1295
Blanchet, 2008, Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1243, 10.1016/j.pnpbp.2008.03.024
Blok, 1996, Modulation of inflammation and cytokine production by dietary (n-3) fatty acids, J. Nutr, 126, 1515, 10.1093/jn/126.6.1515
Bournival, 2012, Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system, Oxid. Med. Cell. Longev, 2012, 921941, 10.1155/2012/921941
Bournival, 2009, Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons, Cell. Mol. Neurobiol, 29, 1169, 10.1007/s10571-009-9411-5
Bousquet, 2011a, Impact of omega-3 fatty acids in Parkinson's disease, Ageing Res. Rev, 10, 453, 10.1016/j.arr.2011.03.001
Bousquet, 2008, Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease, FASEB J, 22, 1213, 10.1096/fj.07-9677com
Bousquet, 2011b, High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice, Neurobiol. Dis, 45, 529, 10.1016/j.nbd.2011.09.009
Bureau, 2008, Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation, J. Neurosci. Res, 86, 403, 10.1002/jnr.21503
Calon, 2005, Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease, Eur. J. Neurosci, 22, 617, 10.1111/j.1460-9568.2005.04253.x
Calon, 2004, Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model, Neuron, 43, 633, 10.1016/j.neuron.2004.08.013
Cansev, 2008, Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease, Neurosci. Res, 62, 206, 10.1016/j.neures.2008.07.005
Cassani, 2013, Cardiometabolic factors and disease duration in patients with Parkinson's disease, Nutrition, 29, 1331, 10.1016/j.nut.2013.04.013
Chan, 2009, Calcium homeostasis, selective vulnerability and Parkinson's disease, Trends Neurosci, 32, 249, 10.1016/j.tins.2009.01.006
Chan, 1998, Genetic and environmental risk factors for Parkinson's disease in a Chinese population, J. Neurol. Neurosurg. Psychiatry, 65, 781, 10.1136/jnnp.65.5.781
Chaturvedi, 2006, Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease, Neurobiol. Dis, 22, 421, 10.1016/j.nbd.2005.12.008
Checkoway, 2002, Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake, Am. J. Epidemiol, 155, 732, 10.1093/aje/155.8.732
Chen, 2007a, Consumption of dairy products and risk of Parkinson's disease, Am. J. Epidemiol, 165, 998, 10.1093/aje/kwk089
Chen, 2002, Diet and Parkinson's disease: a potential role of dairy products in men, Ann. Neurol, 52, 793, 10.1002/ana.10381
Chen, 2003, Dietary intakes of fat and risk of Parkinson's disease, Am. J. Epidemiol, 157, 1007, 10.1093/aje/kwg073
Chen, 2004, Folate intake and risk of Parkinson's disease, Am. J. Epidemiol, 160, 368, 10.1093/aje/kwh213
Chen, 2007b, Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and “fine tuning†modulation, Prog. Neurobiol, 83, 310, 10.1016/j.pneurobio.2007.09.002
Chen, 2001, Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease, J. Neurosci, 21, RC143, 10.1523/JNEUROSCI.21-10-j0001.2001
Chi, 1992, Effects of MPTP and vitamin E treatments on immune function in mice, Int. J. Immunopharmacol, 14, 739, 10.1016/0192-0561(92)90070-2
Choi, 2005a, Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey, Arthritis Rheum, 52, 283, 10.1002/art.20761
Choi, 2005b, Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity, Free Radic. Biol. Med, 38, 806, 10.1016/j.freeradbiomed.2004.12.008
Choi, 2002, Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate, Neurotoxicology, 23, 367, 10.1016/S0161-813X(02)00079-7
Cleren, 2008, Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism, J. Neurochem, 104, 1613, 10.1111/j.1471-4159.2007.05097.x
Coimbra, 2003, High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients, Braz. J. Med. Biol. Res, 36, 1409, 10.1590/S0100-879X2003001000019
Colette, 2003, Exchanging carbohydrates for monounsaturated fats in energy-restricted diets: effects on metabolic profile and other cardiovascular risk factors, Int. J. Obes. Relat. Metab. Disord, 27, 648, 10.1038/sj.ijo.0802299
Corrigan, 1998, Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease, Exp. Neurol, 150, 339, 10.1006/exnr.1998.6776
Costa, 2010, Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies, J. Alzheimers Dis, 20, S221, 10.3233/JAD-2010-091525
Crevoisier, 2003, Effects of food on the pharmacokinetics of levodopa in a dual-release formulation, Eur. J. Pharm. Biopharm, 55, 71, 10.1016/S0939-6411(02)00124-8
Da Silva, 2008, Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation, J. Affect. Disord, 111, 351, 10.1016/j.jad.2008.03.008
Dauncey, 1997, From early nutrition and later development… to underlying mechanisms and optimal health, Br. J. Nutr, 78, S113, 10.1079/BJN19970226
Dauncey, 2012, Recent advances in nutrition, genes and brain health, Proc. Nutr. Soc, 71, 581, 10.1017/S0029665112000237
Dauncey, 2013, Genomic and epigenomic insights into nutrition and brain disorders, Nutrients, 5, 887, 10.3390/nu5030887
Dauncey, 1999, Nutrition and neurodevelopment: mechanisms of developmental dysfunction and disease in later life, Nutr. Res. Rev, 12, 231, 10.1079/095442299108728947
Dauncey, 2001, Nutrition-hormone receptor-gene interactions: implications for development and disease, Proc. Nutr. Soc, 60, 63, 10.1079/PNS200071
De Lau, 2005, Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study, Neurology, 64, 2040, 10.1212/01.WNL.0000166038.67153.9F
De Lau, 2006, Serum cholesterol levels and the risk of Parkinson's disease, Am. J. Epidemiol, 164, 998, 10.1093/aje/kwj283
De Urquiza, 2000, Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain, Science, 290, 2140, 10.1126/science.290.5499.2140
Du, 2012, Serum cholesterol and nigrostriatal R2* values in Parkinson's disease, PLoS ONE, 7, e35397, 10.1371/journal.pone.0035397
Etminan, 2005, Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis, Lancet Neurol, 4, 362, 10.1016/S1474-4422(05)70097-1
Fahn, 1992, A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease, Ann. Neurol, 32, S128, 10.1002/ana.410320722
Fall, 1999, Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden, Mov. Disord, 14, 28, 10.1002/1531-8257(199901)14:128::AID-MDS10073.0.CO;2-O
Farooqui, 1998, Lipid peroxides in the free radical pathophysiology of brain diseases, Cell. Mol. Neurobiol, 18, 599, 10.1023/A:1020261600498
Fernandez-Calle, 1992, Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease, Neurology, 42, 1064, 10.1212/WNL.42.5.1064
Fernstrom, 1999, Effects of dietary polyunsaturated fatty acids on neuronal function, Lipids, 34, 161, 10.1007/s11745-999-0350-3
Fernstrom, 1979, Diurnal variations in plasma concentrations of tryptophan, tryosine, and other neutral amino acids: effect of dietary protein intake, Am. J. Clin. Nutr, 32, 1912, 10.1093/ajcn/32.9.1912
Ferraz, 2004, Comments on the paper “High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients. C.G. Coimbra and V.B.C. Junqueira. Brazilian Journal of Medical and Biological Research, 36: 1409-1417, 2003â€, Braz. J. Med. Biol. Res, 37, 1297, 10.1590/S0100-879X2004000900002
Fleming, 1994, Parkinson's disease and brain levels of organochlorine pesticides, Ann. Neurol, 36, 100, 10.1002/ana.410360119
Gaenslen, 2008, Nutrition and the risk for Parkinson's disease: review of the literature, J. Neural Transm, 115, 703, 10.1007/s00702-007-0005-4
Gao, 2008, Diet, urate, and Parkinson's disease risk in men, Am. J. Epidemiol, 167, 831, 10.1093/aje/kwm385
Gao, 2007, Prospective study of dietary pattern and risk of Parkinson disease, Am. J. Clin. Nutr, 86, 1486, 10.1093/ajcn/86.5.1486
Garcion, 2002, New clues about vitamin D functions in the nervous system, Trends Endocrinol. Metab, 13, 100, 10.1016/S1043-2760(01)00547-1
Gasior, 2006, Neuroprotective and disease-modifying effects of the ketogenic diet, Behav. Pharmacol, 17, 431, 10.1097/00008877-200609000-00009
Gleichmann, 2011, Neuronal calcium homeostasis and dysregulation, Antioxid. Redox Signal, 14, 1261, 10.1089/ars.2010.3386
Golembiowska, 2012, The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2, Neurotox. Res, 22, 150, 10.1007/s12640-012-9316-9
Gong, 1991, Vitamin E supplements fail to protect mice from acute MPTP neurotoxicity, Neuroreport, 2, 544, 10.1097/00001756-199109000-00012
Gosslau, 2011, Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo, Mol. Nutr. Food Res, 55, 198, 10.1002/mnfr.201000165
Green, 2007, Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels, J. Neurosci, 27, 4385, 10.1523/JNEUROSCI.0055-07.2007
Guo, 2007, Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway, Biol. Psychiatry, 62, 1353, 10.1016/j.biopsych.2007.04.020
Hackett, 2012, Parallel mechanisms of epigenetic reprogramming in the germline, Trends Genet, 28, 164, 10.1016/j.tig.2012.01.005
Hartman, 2006, Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease, Neurobiol. Dis, 24, 506, 10.1016/j.nbd.2006.08.006
Hashimoto, 2005, Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats, J. Nutr, 135, 549, 10.1093/jn/135.3.549
Hassan, 2010, An alpha-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-kappaB in rats with TNBS-induced colitis, J. Nutr, 140, 1714, 10.3945/jn.109.119768
Hellenbrand, 1996a, Diet and Parkinson's disease. II: a possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study, Neurology, 47, 644, 10.1212/WNL.47.3.644
Hellenbrand, 1996b, Diet and Parkinson's disease. I: a possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study, Neurology, 47, 636, 10.1212/WNL.47.3.636
Hellenbrand, 1997, Smoking and Parkinson's disease: a case-control study in Germany, Int. J. Epidemiol, 26, 328, 10.1093/ije/26.2.328
Hernan, 2003, Alcohol consumption and the incidence of Parkinson's disease, Ann. Neurol, 54, 170, 10.1002/ana.10611
Hickey, 2011, Available and emerging treatments for Parkinson's disease: a review, Drug Des. Devel. Ther, 5, 241, 10.2147/DDDT.S11836
Horrocks, 1999, Health benefits of docosahexaenoic acid (DHA), Pharmacol. Res, 40, 211, 10.1006/phrs.1999.0495
Hu, 2010, Total cholesterol and the risk of Parkinson's disease: a review for some new findings, Parkinsons Dis, 2010, 836962, 10.4061/2010/836962
Hu, 2007, Coffee and tea consumption and the risk of Parkinson's disease, Mov. Disord, 22, 2242, 10.1002/mds.21706
Huang, 2011, Serum cholesterol and the progression of Parkinson's disease: results from DATATOP, PLoS ONE, 6, e22854, 10.1371/journal.pone.0022854
Jin, 2008, Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats, Eur. J. Pharmacol, 600, 78, 10.1016/j.ejphar.2008.10.005
Joghataie, 2004, Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence, Parkinsonism Relat. Disord, 10, 465, 10.1016/j.parkreldis.2004.06.004
Johnson, 1999, Adult nutrient intake as a risk factor for Parkinson's disease, Int. J. Epidemiol, 28, 1102, 10.1093/ije/28.6.1102
Jump, 2002, Dietary polyunsaturated fatty acids and regulation of gene transcription, Curr. Opin. Lipidol, 13, 155, 10.1097/00041433-200204000-00007
Kachroo, 2010, Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration, Exp. Neurol, 223, 657, 10.1016/j.expneurol.2010.02.007
Kaikkonen, 1999, Determinants of plasma coenzyme Q10 in humans, FEBS Lett, 443, 163, 10.1016/S0014-5793(98)01712-8
Kamel, 2013, Epidemiology. Paths from pesticides to Parkinson's, Science, 341, 722, 10.1126/science.1243619
Kamel, 2013, Dietary fat intake, pesticide use, and Parkinson's disease, Parkinsonism Relat. Disord, 20, 82, 10.1016/j.parkreldis.2013.09.023
Kandinov, 2009, Smoking and tea consumption delay onset of Parkinson's disease, Parkinsonism Relat. Disord, 15, 41, 10.1016/j.parkreldis.2008.02.011
Kaur, 2011, Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease, Neurochem. Res, 36, 1435, 10.1007/s11064-011-0469-3
Khan, 2010, Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease, Brain Res, 1328, 139, 10.1016/j.brainres.2010.02.031
Kim, 2001, Inhibition of neuronal apoptosis by polyunsaturated fatty acids, J. Mol. Neurosci, 16, 223, 10.1385/JMN:16:2-3:223
Kim, 2010, Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease, J.Clin. Neurosci, 17, 1165, 10.1016/j.jocn.2010.01.042
Kim, 2011, Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells, J. Clin. Invest, 121, 3701, 10.1172/JCI44736
Kim, 2000, Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols, Nutr. Cancer, 37, 41, 10.1207/S15327914NC3701_5
Kish, 1985, Glutathione peroxidase activity in Parkinson's disease brain, Neurosci. Lett, 58, 343, 10.1016/0304-3940(85)90078-3
Kitada, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416
Kotagal, 2013, Diabetes is associated with postural instability and gait difficulty in Parkinson disease, Parkinsonism Relat. Disord, 19, 522, 10.1016/j.parkreldis.2013.01.016
Kyrozis, 2013, Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece, Eur. J. Epidemiol, 28, 67, 10.1007/s10654-012-9760-0
Kyuhou, 2008, Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats, Neurosci. Lett, 448, 10, 10.1016/j.neulet.2008.10.045
Lamperti, 1991, Decreased concentration of low density lipoprotein cholesterol in patients with parkinson's disease, Clinical Research, Vol. 39, 401A
Lan, 1997, Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice, J. Neural Transm, 104, 469, 10.1007/BF01277665
Langie, 2012, Early determinants of the ageing trajectory, Best Pract. Res. Clin. Endocrinol. Metab, 26, 613, 10.1016/j.beem.2012.03.004
Leaver, 2009, Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection, Brain Res. Bull, 80, 397, 10.1016/j.brainresbull.2009.08.013
Levites, 2001, Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration, J. Neurochem, 78, 1073, 10.1046/j.1471-4159.2001.00490.x
Lewitt, 1994, Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment, J. Neural Transm. Suppl, 43, 171
Li, 2004, (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury, J. Neurosci. Res, 78, 723, 10.1002/jnr.20315
Liu, 2008, Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease, Neurosci. Res, 60, 156, 10.1016/j.neures.2007.10.005
Liu, 2013, Alcohol consumption, types of alcohol, and Parkinson's disease, PLoS ONE, 8, e66452, 10.1371/journal.pone.0066452
Liu, 2003, Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals, Am. J. Clin. Nutr, 78, 517S-520S, 10.1093/ajcn/78.3.517S
Logroscino, 2008, Dietary iron intake and risk of Parkinson's disease, Am. J. Epidemiol, 168, 1381, 10.1093/aje/kwn273
Logroscino, 1996, Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study, Ann. Neurol, 39, 89, 10.1002/ana.410390113
Logroscino, 1998, Dietary iron, animal fats, and risk of Parkinson's disease, Mov. Disord, 13, 13
Lu, 2008, Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging, J. Agric. Food Chem, 56, 6910, 10.1021/jf8007212
Luchtman, 2012, Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease, Behav. Brain Res, 226, 386, 10.1016/j.bbr.2011.09.033
Luchtman, 2013, omega-3 fatty acid eicosapentaenoic acid attenuates MPP+-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells, J. Neurochem, 124, 855, 10.1111/jnc.12068
Massaro, 2006, The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition, Proc. Natl. Acad. Sci. U.S.A, 103, 15184, 10.1073/pnas.0510086103
Massey, 2000, The chemical and biological versatility of riboflavin, Biochem. Soc. Trans, 28, 283, 10.1042/0300-5127:0280283
Mattson, 2014, Interventions that improve body and brain bioenergetics for Parkinson's disease risk reduction and therapy, J. Parkinsons Dis, 4, 1, 10.3233/JPD-130335
Meng, 2010, Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices, Eur. J. Pharmacol, 649, 127, 10.1016/j.ejphar.2010.09.046
Micha, 2010, Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis, Circulation, 121, 2271, 10.1161/CIRCULATIONAHA.109.924977
Miyake, 2011a, Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan, Eur. J. Neurol, 18, 106, 10.1111/j.1468-1331.2010.03088.x
Miyake, 2011b, Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan, J. Neurol. Sci, 306, 98, 10.1016/j.jns.2011.03.035
Miyake, 2011c, Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: a case-control study in Japan, Parkinsonism Relat. Disord, 17, 112, 10.1016/j.parkreldis.2010.11.018
Morelli, 2010, Pathophysiological roles for purines: adenosine, caffeine and urate, Prog. Brain Res, 183, 183, 10.1016/S0079-6123(10)83010-9
Moreno, 2003, The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review), J. Nutr. Biochem, 14, 182, 10.1016/S0955-2863(02)00294-2
Morris, 2010, Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet, Am. J. Physiol. Regul. Integr. Comp. Physiol, 299, R1082, 10.1152/ajpregu.00449.2010
Morroni, 2013, Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease, Neurotoxicology, 36, 63, 10.1016/j.neuro.2013.03.004
Murakami, 2010a, Dietary glycemic index is inversely associated with the risk of Parkinson's disease: a case-control study in Japan, Nutrition, 26, 515, 10.1016/j.nut.2009.05.021
Murakami, 2010b, Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan, Br. J. Nutr, 104, 757, 10.1017/S0007114510001005
Musanti, 1993, Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease, Biochem. Med. Metab. Biol, 49, 133, 10.1006/bmmb.1993.1016
Nakaso, 2008, Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells, Neurosci. Lett, 432, 146, 10.1016/j.neulet.2007.12.034
Nie, 2002, Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells, Redox Rep, 7, 171, 10.1179/135100002125000424
Noyce, 2012, Meta-analysis of early nonmotor features and risk factors for Parkinson disease, Ann. Neurol, 72, 893, 10.1002/ana.23687
Oba, 2013, Dietary glycemic index, glycemic load and incidence of type 2 diabetes in Japanese men and women: the Japan public health center-based prospective study, Nutr. J, 12, 165, 10.1186/1475-2891-12-165
Offen, 1996, Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease, Exp. Neurol, 141, 32, 10.1006/exnr.1996.0136
Okawara, 2007, Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults, Biochem. Pharmacol, 73, 550, 10.1016/j.bcp.2006.11.003
Okubo, 2012, Dietary patterns and risk of Parkinson's disease: a case-control study in Japan, Eur. J. Neurol, 19, 681, 10.1111/j.1468-1331.2011.03600.x
O'Reilly, 2010, Plasma urate and Parkinson's disease in women, Am. J. Epidemiol, 172, 666, 10.1093/aje/kwq195
Osakada, 2004, Alpha-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons, Neuropharmacology, 47, 904, 10.1016/j.neuropharm.2004.06.029
Ozsoy, 2011, The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease, Neurochem. Int, 59, 664, 10.1016/j.neuint.2011.06.012
Paiva, 1999, Beta-carotene and other carotenoids as antioxidants, J. Am. Coll. Nutr, 18, 426, 10.1080/07315724.1999.10718880
Palacios, 2011, Obesity, diabetes, and risk of Parkinson's disease, Mov. Disord, 26, 2253, 10.1002/mds.23855
Palacios, 2012a, Caffeine and risk of Parkinson's disease in a large cohort of men and women, Mov. Disord, 27, 1276, 10.1002/mds.25076
Palacios, 2012b, Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women, Mov. Disord, 27, 980, 10.1002/mds.25050
Pallas, 2009, Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection, Curr. Neurovasc. Res, 6, 70, 10.2174/156720209787466019
Pan, 2003a, Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury, Life Sci, 72, 1073, 10.1016/S0024-3205(02)02347-0
Pan, 2003b, Potential therapeutic properties of green tea polyphenols in Parkinson's disease, Drugs Aging, 20, 711, 10.2165/00002512-200320100-00001
Pare, 1992, Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients, Am. J. Clin. Nutr, 55, 701, 10.1093/ajcn/55.3.701
Park, 2012, Nutritional influences on epigenetics and age-related disease, Proc. Nutr. Soc, 71, 75, 10.1017/S0029665111003302
Park, 2005, Consumption of milk and calcium in midlife and the future risk of Parkinson disease, Neurology, 64, 1047, 10.1212/01.WNL.0000154532.98495.BF
Peers, 1997, Fatty diet, mitochondria and Parkinson's disease, N. Z. Med. J, 110, 132
Perry, 1985, Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse, Neurosci. Lett, 60, 109, 10.1016/0304-3940(85)90229-0
Perry, 1987, Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J. Neurol. Sci, 81, 321, 10.1016/0022-510X(87)90106-7
Pincus, 1987, Plasma levels of amino acids correlate with motor fluctuations in parkinsonism, Arch. Neurol, 44, 1006, 10.1001/archneur.1987.00520220012007
Ponsen, 2004, Idiopathic hyposmia as a preclinical sign of Parkinson's disease, Ann. Neurol, 56, 173, 10.1002/ana.20160
Popoli, 2004, Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadows, Crit. Rev. Neurobiol, 16, 99, 10.1615/CritRevNeurobiol.v16.i12.110
Powers, 2003, Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes, Neurology, 60, 1761, 10.1212/01.WNL.0000068021.13945.7F
Prakash, 2011, Clinical evidence linking coffee and tea intake with Parkinson's disease, Basal Ganglia, 1, 127, 10.1016/j.baga.2011.07.001
Prediger, 2010, Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms, J. Alzheimers Dis, 20, S205, 10.3233/JAD-2010-091459
Qian, 2012, Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-kappaB activation in a cerebral ischemia mouse model, Neurochem. Int, 60, 759, 10.1016/j.neuint.2012.03.011
Qureshi, 2013, Epigenetic mechanisms governing the process of neurodegeneration, Mol. Aspects Med, 34, 875, 10.1016/j.mam.2012.06.011
Ragonese, 2003, A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease, Neuroepidemiology, 22, 297, 10.1159/000071193
Riederer, 1989, Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains, J. Neurochem, 52, 515, 10.1111/j.1471-4159.1989.tb09150.x
Robinson, 2013, N-3 polyunsaturated fatty acids: relationship to inflammation in healthy adults and adults exhibiting features of metabolic syndrome, Lipids, 48, 319, 10.1007/s11745-013-3774-6
Roghani, 2001, Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence, Brain Res, 892, 211, 10.1016/S0006-8993(00)03296-0
Rohrmann, 2013, Meat consumption and mortality–results from the European Prospective Investigation into Cancer and Nutrition, BMC Med, 11, 63, 10.1186/1741-7015-11-63
Ryu, 2002, Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease, J. Neurosci, 22, 10690, 10.1523/JNEUROSCI.22-24-10690.2002
Saaksjarvi, 2013, A cohort study on diet and the risk of Parkinson's disease: the role of food groups and diet quality, Br. J. Nutr, 109, 329, 10.1017/S0007114512000955
Sakamoto, 2007, Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus, Brain Res, 1182, 50, 10.1016/j.brainres.2007.08.089
Salem, 2000, N-3 polyunsaturated fatty acids accentuate B16 melanoma growth and metastasis through suppression of tumoricidal function of T cells and macrophages, Anticancer Res, 20, 3195
Salmeron, 1997a, Dietary fiber, glycemic load, and risk of NIDDM in men, Diabetes Care, 20, 545, 10.2337/diacare.20.4.545
Salmeron, 1997b, Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women, JAMA, 277, 472, 10.1001/jama.1997.03540300040031
Samadi, 2006, Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys, Ann. Neurol, 59, 282, 10.1002/ana.20738
Santiago, 2013a, Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes, PLoS ONE, 8, e83940, 10.1371/journal.pone.0083940
Santiago, 2013b, Shared dysregulated pathways lead to Parkinson's disease and diabetes, Trends Mol. Med, 19, 176, 10.1016/j.molmed.2013.01.002
Santos, 2008, Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures, Pharmacol. Biochem. Behav, 89, 1, 10.1016/j.pbb.2007.10.007
Sarkaki, 2009, Preventive effects of soy meal (+/- isoflavone) on spatial cognitive deficiency and body weight in an ovariectomized animal model of Parkinson's disease, Pak. J. Biol. Sci, 12, 1338, 10.3923/pjbs.2009.1338.1345
Sato, 1997, High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease, Neurology, 49, 1273, 10.1212/WNL.49.5.1273
Scheider, 1997, Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease, Mov. Disord, 12, 190, 10.1002/mds.870120209
Schernhammer, 2011, Diabetes and the risk of developing Parkinson's disease in Denmark, Diabetes Care, 34, 1102, 10.2337/dc10-1333
Schipper, 2000, Heme oxygenase-1: role in brain aging and neurodegeneration, Exp. Gerontol, 35, 821, 10.1016/S0531-5565(00)00148-0
Searles Nielsen, 2013, Nicotine from edible Solanaceae and risk of Parkinson disease, Ann. Neurol, 74, 472, 10.1002/ana.23884
Serhan, 2011, Resolvins and protectins in inflammation resolution, Chem. Rev, 111, 5922, 10.1021/cr100396c
Shaltiel-Karyo, 2013, A blood-brain barrier (BBB) disrupter is also a potent alpha-synuclein (alpha-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD), J. Biol. Chem, 288, 17579, 10.1074/jbc.M112.434787
Shen, 2013, Serum urate and the risk of Parkinson's disease: results from a meta-analysis, Can. J. Neurol. Sci, 40, 73, 10.1017/S0317167100012981
Shimura, 2000, Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase, Nat. Genet, 25, 302, 10.1038/77060
Shults, 2004, Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease, Exp. Neurol, 188, 491, 10.1016/j.expneurol.2004.05.003
Simon, 2007, Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease, Neurology, 69, 1688, 10.1212/01.wnl.0000271883.45010.8a
Simopoulos, 1999, Essential fatty acids in health and chronic disease, Am. J. Clin. Nutr, 70, 560S, 10.1093/ajcn/70.3.560s
Smith, 2006, Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine, Neurochem. Res, 31, 533, 10.1007/s11064-006-9048-4
Song, 2009, Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment, J. Neurosci, 29, 14, 10.1523/JNEUROSCI.3569-08.2009
Sonsalla, 2012, Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease, Exp. Neurol, 234, 482, 10.1016/j.expneurol.2012.01.022
Storch, 2000, 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism, J. Neural Transm, 107, 281, 10.1007/s007020050023
Sun, 2012, Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications, Diabetes Care, 35, 1047, 10.2337/dc11-1511
Suzuki, 2013, Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease, Am. J. Clin. Nutr, 97, 1004, 10.3945/ajcn.112.051664
Taepavarapruk, 2010, Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment, J. Neurochem, 112, 1054, 10.1111/j.1471-4159.2009.06524.x
Tan, 2008, Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study, Am. J. Epidemiol, 167, 553, 10.1093/aje/kwm338
Tanaka, 2011, Intake of Japanese and Chinese teas reduces risk of Parkinson's disease, Parkinsonism Relat. Disord, 17, 446, 10.1016/j.parkreldis.2011.02.016
Tapias, 2013, Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease, Neurobiol. Aging, 35, 1162, 10.1016/j.neurobiolaging.2013.10.077
Tarozzi, 2013, Sulforaphane as a potential protective phytochemical against neurodegenerative diseases, Oxid. Med. Cell. Longev, 2013, 415078, 10.1155/2013/415078
Tarozzi, 2012, Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line, Int. J. Mol. Sci, 13, 10899, 10.3390/ijms130910899
Uttara, 2009, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options, Curr. Neuropharmacol, 7, 65, 10.2174/157015909787602823
Vanitallie, 2005, Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study, Neurology, 64, 728, 10.1212/01.WNL.0000152046.11390.45
Wang, 2003, Effect of docosahexaenoic acid and ascorbate on peroxidation of retinal membranes of ODS rats, Free Radic. Res, 37, 419, 10.1080/1071576031000070084
Wang, 2001, Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats, Brain Res, 904, 67, 10.1016/S0006-8993(01)02450-7
Wang, 2014, Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice, Exp. Neurol, 251, 22, 10.1016/j.expneurol.2013.11.001
Wang, 2005, Genistein protects dopaminergic neurons by inhibiting microglial activation, Neuroreport, 16, 267, 10.1097/00001756-200502280-00013
Warner, 2003, Genetic and environmental factors in the cause of Parkinson's disease, Ann. Neurol, 53, S16, 10.1002/ana.10487
Weinreb, 2009, Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties, Genes Nutr, 4, 283, 10.1007/s12263-009-0143-4
Weinreb, 2004, Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases, J. Nutr. Biochem, 15, 506, 10.1016/j.jnutbio.2004.05.002
Weisskopf, 2007, Plasma urate and risk of Parkinson's disease, Am. J. Epidemiol, 166, 561, 10.1093/aje/kwm127
Wu, 2004, Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats, J. Neurotrauma, 21, 1457, 10.1089/neu.2004.21.1457
Wurtman, 2006, Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally, Brain Res, 1088, 83, 10.1016/j.brainres.2006.03.019
Wurtman, 2003, Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios, Am. J. Clin. Nutr, 77, 128, 10.1093/ajcn/77.1.128
Xiao, 2011, Deletion of adenosine A(1) or A((2)A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease, Brain Res, 1367, 310, 10.1016/j.brainres.2010.08.099
Xu, 2006, Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, J. Neurosci, 26, 535, 10.1523/JNEUROSCI.3008-05.2006
Xu, 2002, Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice, Neurosci. Lett, 322, 13, 10.1016/S0304-3940(02)00069-1
Xu, 2010, Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease, Neuroscience, 167, 475, 10.1016/j.neuroscience.2010.02.020
Yadav, 2012, Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse, Neurochem. Res, 37, 875, 10.1007/s11064-011-0682-0
Ye, 2012, Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1alpha signaling pathway, BMC Complement. Altern. Med, 12, 82, 10.1186/1472-6882-12-82
Yong, 1986, Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment, Neurosci. Lett, 63, 56, 10.1016/0304-3940(86)90012-1
Youdim, 2000, Essential fatty acids and the brain: possible health implications, Int. J. Dev. Neurosci, 18, 383, 10.1016/S0736-5748(00)00013-7
Zhang, 2010, Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions, Mol. Pharmacol, 78, 466, 10.1124/mol.110.064535
Zhang, 2002, Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk, Neurology, 59, 1161, 10.1212/01.WNL.0000028688.75881.12
Zhang, 2013, Alpha-linolenic acid exerts an endothelial protective effect against high glucose injury via PI3K/Akt pathway, PLoS ONE, 8, e68489, 10.1371/journal.pone.0068489
Zhao, 2009, Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease, Neurochem. Res, 34, 630, 10.1007/s11064-008-9900-9